Granted Patent
B2
US 8,269,005 · App. 12/498,756 · Granted Sep 18, 2012
L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
Assignee:
Sunovion Pharmaceuticals Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
L-malate salts of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) are provided.
Claims (2)
1. A method for providing blood levels of zopiclone that are independent of fasting state of a patient comprising administering to said patient an effective amount of an L-malate salt of zopiclone.
2. A method for providing blood levels of eszopiclone that are independent of fasting state of a patient comprising administering to said patient an effective amount of an L-malate salt of eszopiclone.
Assignments (2)
CHANGE OF NAME
Recorded Jan 26, 2011
From: SEPRACOR INC.
To: SUNOVION PHARMACEUTICALS INC.
Reel/Frame 025699/0042 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 1, 2009
From: WILKINSON, H. SCOTT; HSIA, RICHARD; MISRA, TUSHAR; SARANTEAS, KOSTAS
To: SEPRACOR INC.
Reel/Frame 023315/0780 →
Continuity (3)
Provisional Application
61008363
· Dec 19, 2007